Pfizer’s Paxlovid Becomes First Oral COVID-19 Drug To Get FDA Approval

FDA on Thursday (May 25) approved Pfizer’s COVID-19 drug Paxlovid -- making it the first oral antiviral pill approved to treat coronavirus in adults ages 18 and older who are at high risk for progressing to severe disease -- a little more than two months after a panel of agency advisers backed the pill while also calling for more data on so-called rebound cases of COVID-19 and urging FDA to include clear information about drug-drug interactions on the product label...